| Product Code: ETC9679671 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Benign Prostatic Hyperplasia Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Benign Prostatic Hyperplasia Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Benign Prostatic Hyperplasia Market - Industry Life Cycle |
3.4 Thailand Benign Prostatic Hyperplasia Market - Porter's Five Forces |
3.5 Thailand Benign Prostatic Hyperplasia Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Thailand Benign Prostatic Hyperplasia Market Revenues & Volume Share, By Distribution Channels, 2021 & 2031F |
4 Thailand Benign Prostatic Hyperplasia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of benign prostatic hyperplasia (BPH) in Thailand |
4.2.2 Growing aging population in Thailand |
4.2.3 Rising awareness and education about BPH and available treatment options |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in rural areas of Thailand |
4.3.2 High treatment costs associated with BPH management |
4.3.3 Potential side effects and complications of BPH treatments |
5 Thailand Benign Prostatic Hyperplasia Market Trends |
6 Thailand Benign Prostatic Hyperplasia Market, By Types |
6.1 Thailand Benign Prostatic Hyperplasia Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Benign Prostatic Hyperplasia Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Thailand Benign Prostatic Hyperplasia Market Revenues & Volume, By Alpha-Blockers, 2021- 2031F |
6.1.4 Thailand Benign Prostatic Hyperplasia Market Revenues & Volume, By 5- Alpha-Reductase Inhibitors (5-Aris), 2021- 2031F |
6.1.5 Thailand Benign Prostatic Hyperplasia Market Revenues & Volume, By Alpha-Adrenergic Blockers, 2021- 2031F |
6.1.6 Thailand Benign Prostatic Hyperplasia Market Revenues & Volume, By Phosphodiesterase-5 Enzyme Inhibitors, 2021- 2031F |
6.1.7 Thailand Benign Prostatic Hyperplasia Market Revenues & Volume, By Other Drug Types, 2021- 2031F |
6.2 Thailand Benign Prostatic Hyperplasia Market, By Distribution Channels |
6.2.1 Overview and Analysis |
6.2.2 Thailand Benign Prostatic Hyperplasia Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.2.3 Thailand Benign Prostatic Hyperplasia Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.2.4 Thailand Benign Prostatic Hyperplasia Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Thailand Benign Prostatic Hyperplasia Market Import-Export Trade Statistics |
7.1 Thailand Benign Prostatic Hyperplasia Market Export to Major Countries |
7.2 Thailand Benign Prostatic Hyperplasia Market Imports from Major Countries |
8 Thailand Benign Prostatic Hyperplasia Market Key Performance Indicators |
8.1 Average wait time for BPH treatment in Thailand |
8.2 Number of healthcare facilities offering specialized BPH treatments |
8.3 Percentage of men over 50 undergoing regular prostate screenings |
8.4 Adoption rate of minimally invasive BPH treatments |
8.5 Patient satisfaction with BPH treatment outcomes |
9 Thailand Benign Prostatic Hyperplasia Market - Opportunity Assessment |
9.1 Thailand Benign Prostatic Hyperplasia Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Thailand Benign Prostatic Hyperplasia Market Opportunity Assessment, By Distribution Channels, 2021 & 2031F |
10 Thailand Benign Prostatic Hyperplasia Market - Competitive Landscape |
10.1 Thailand Benign Prostatic Hyperplasia Market Revenue Share, By Companies, 2024 |
10.2 Thailand Benign Prostatic Hyperplasia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here